Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ulcerative Colitis, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07577856
What this trial is testing

JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 644
Testing effectiveness (Phase 2)Study completedNCT00063830
What this trial is testing

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07335055
What this trial is testing

HSK47388 in Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Haisco Pharmaceutical Group Co., Ltd. 150
Not applicableStudy completedNCT06998693
What this trial is testing

A Single-Center Observational Study on the Impact of Symptom Assessment Timing on the Short-Term Efficacy of 5-ASA Therapy in Patients With Initial-Onset or Relapsed Mild-to-Moderate Active Ulcerative Colitis

Who this might be right for
Ul
Xijing Hospital of Digestive Diseases 180
Large-scale testing (Phase 3)Study completedNCT00679380
What this trial is testing

(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 514
Large-scale testing (Phase 3)Study completedNCT02100696
What this trial is testing

The Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 609
Post-approval studies (Phase 4)Study completedNCT02559713
What this trial is testing

Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn's Disease
Takeda 11
Not applicableUnknownNCT03788824
What this trial is testing

Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE

Who this might be right for
Inflammation
Shandong University 70
Not applicableStudy completedNCT03549988
What this trial is testing

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

Who this might be right for
Ulcerative Colitis
University of British Columbia 726
Not applicableStudy completedNCT02717897
What this trial is testing

Vitamin D and Disease Activity in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Chicago 248
Testing effectiveness (Phase 2)WithdrawnNCT05539625
What this trial is testing

Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Edinburgh
Not applicableNot Yet RecruitingNCT07781215
What this trial is testing

E-nose in Evaluating Colitis Activity

Who this might be right for
IBD (Inflammatory Bowel Disease)
Tampere University Hospital 120
Not applicableActive Not RecruitingNCT05494606
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Who this might be right for
Ulcerative Colitis
AbbVie 785
Early research (Phase 1)Study completedNCT02883452
What this trial is testing

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative Colitis (Part 2 Only)
Celltrion 181
Testing effectiveness (Phase 2)Study completedNCT03235752
What this trial is testing

Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis
I-Mab Biopharma HongKong Limited 91
Not applicableLooking for participantsNCT07686406
What this trial is testing

IBD Biomarker Discovery and Validation Platform

Who this might be right for
Crohn Disease (CD)Ulcerative Colitis (UC)Inflammatory Bowel Diseases (IBD)
Sixth Affiliated Hospital, Sun Yat-sen University 6,000
Early research (Phase 1)Study completedNCT03849599
What this trial is testing

Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Provention Bio, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT02606032
What this trial is testing

Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hamilton Health Sciences Corporation 75
Not applicableUnknownNCT00793130
What this trial is testing

The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label

Who this might be right for
Ulcerative Colitis
Tel-Aviv Sourasky Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06867042
What this trial is testing

Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis, Active Moderate
Jina Pharmaceuticals Inc. 150
Next Page